141 related articles for article (PubMed ID: 18331322)
1. Long-term efficacy of etanercept in hidradenitis suppurativa.
Zangrilli A; Esposito M; Mio G; Mazzotta A; Chimenti S
J Eur Acad Dermatol Venereol; 2008 Nov; 22(10):1260-2. PubMed ID: 18331322
[No Abstract] [Full Text] [Related]
2. Etanercept for the treatment of hidradenitis suppurativa.
Sotiriou E; Apalla Z; Ioannidos D
Acta Derm Venereol; 2009; 89(1):82-3. PubMed ID: 19197548
[No Abstract] [Full Text] [Related]
3. Long-term efficacy of etanercept in hidradenitis suppurativa: results from an open-label phase II prospective trial.
Pelekanou A; Kanni T; Savva A; Mouktaroudi M; Raftogiannis M; Kotsaki A; Giamarellos-Bourboulis EJ
Exp Dermatol; 2010 Jun; 19(6):538-40. PubMed ID: 19758320
[TBL] [Abstract][Full Text] [Related]
4. Case reports: treatment of atypical hidradenitis suppurativa with the tumor necrosis factor receptor-Fc fusion protein etanercept.
Henderson RL
J Drugs Dermatol; 2006; 5(10):1010-1. PubMed ID: 17373153
[TBL] [Abstract][Full Text] [Related]
5. Etanercept: effective in the management of hidradenitis suppurativa.
Cusack C; Buckley C
Br J Dermatol; 2006 Apr; 154(4):726-9. PubMed ID: 16536817
[TBL] [Abstract][Full Text] [Related]
6. Rotational therapy with TNF-alpha blockers for recalcitrant hidradenitis suppurativa.
Brunasso AM; Massone C
Eur J Dermatol; 2010; 20(5):644-6. PubMed ID: 20615818
[No Abstract] [Full Text] [Related]
7. An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa.
Giamarellos-Bourboulis EJ; Pelekanou E; Antonopoulou A; Petropoulou H; Baziaka F; Karagianni V; Stavrianeas N; Giamarellou H
Br J Dermatol; 2008 Mar; 158(3):567-72. PubMed ID: 18076705
[TBL] [Abstract][Full Text] [Related]
8. Bilateral Candida chorioretinitis following etanercept treatment for hidradenitis suppurativa.
Arriola-Villalobos P; Díaz-Valle D; Alejandre-Alba N; López-Abad C; Méndez-Fernández R; Benítez-del-Castillo JM
Eye (Lond); 2008 Apr; 22(4):599-600. PubMed ID: 18239677
[No Abstract] [Full Text] [Related]
9. Biologic drugs for the treatment of hidradenitis suppurativa: an evidence-based review.
Shuja F; Chan CS; Rosen T
Dermatol Clin; 2010 Jul; 28(3):511-21, 523-4; quiz 522-3. PubMed ID: 20510761
[TBL] [Abstract][Full Text] [Related]
10. Moderate to severe hidradenitis suppurativa treated with biological therapies.
Chinniah N; Cains GD
Australas J Dermatol; 2014 May; 55(2):128-31. PubMed ID: 24456051
[TBL] [Abstract][Full Text] [Related]
11. A prospective clinical trial of open-label etanercept for the treatment of hidradenitis suppurativa.
Lee RA; Dommasch E; Treat J; Sciacca-Kirby J; Chachkin S; Williams J; Shin DB; Leyden JJ; Vittorio C; Gelfand JM
J Am Acad Dermatol; 2009 Apr; 60(4):565-73. PubMed ID: 19185954
[TBL] [Abstract][Full Text] [Related]
12. Etanercept induced hidradenitis suppurativa.
Pellegrino M; Taddeucci P; Peccianti C; Mei S; Fioravanti A; Fimiani M
G Ital Dermatol Venereol; 2011 Dec; 146(6):503-4. PubMed ID: 22095184
[No Abstract] [Full Text] [Related]
13. Current and emerging nonsurgical treatment options for hidradenitis suppurativa.
Kerdel FA
Semin Cutan Med Surg; 2014 Jun; 33(3 Suppl):S57-9. PubMed ID: 25188460
[TBL] [Abstract][Full Text] [Related]
14. Use of biological treatments in patients with hidradenitis suppurativa.
Martin-Ezquerra G; Masferrer E; Masferrer-Niubò M; Ferran M; Sánchez-Regaña M; Collgros H; Bordas X; Notario J; Alsina M; Gil I; Izquierdo N; Aparicio G; Mollet J; Garcia-Patos V; Pujol RM
J Eur Acad Dermatol Venereol; 2015 Jan; 29(1):56-60. PubMed ID: 24629001
[TBL] [Abstract][Full Text] [Related]
15. Management of hidradenitis suppurativa with biological therapy: report of four cases and review of the literature.
Bahillo Monné C; Honorato Guerra S; Schoendorff Ortega C; Gargallo Quintero AB
Dermatology; 2014; 229(4):279-87. PubMed ID: 25472035
[TBL] [Abstract][Full Text] [Related]
16. Lack of efficacy of etanercept in acrodermatitis continua of Hallopeau.
Adişen E; Oztaş M; Gürer MA
Int J Dermatol; 2007 Nov; 46(11):1205-7. PubMed ID: 17988345
[No Abstract] [Full Text] [Related]
17. Efficacy of etanercept in lymphedema associated with psoriatic arthritis.
Lekpa FK; Economu-Dubosc A; Fevre C; Claudepierre P; Chevalier X
J Rheumatol; 2009 Jan; 36(1):207-8. PubMed ID: 19208540
[No Abstract] [Full Text] [Related]
18. Hidradenitis suppurativa: are tumour necrosis factor-alpha blockers the ultimate alternative?
Brunasso AM; Delfino C; Massone C
Br J Dermatol; 2008 Sep; 159(3):761-3. PubMed ID: 18627370
[No Abstract] [Full Text] [Related]
19. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
Mazzotta A; Esposito M; Costanzo A; Chimenti S
Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
[TBL] [Abstract][Full Text] [Related]
20. Long-term infliximab for severe hidradenitis suppurativa.
Thielen AM; Barde C; Saurat JH
Br J Dermatol; 2006 Nov; 155(5):1105-7. PubMed ID: 17034567
[No Abstract] [Full Text] [Related]
[Next] [New Search]
